NEW YORK (Reuters Health) – Type 2 diabetics treated with rosiglitazone are at increased risk of heart failure events, researchers report in the January 29th online issue of…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Triple antiplatelet therapy is more effective than dual therapy at reducing ischemic events after implantation of a drug-eluting stent (DES), according to an…
NEW YORK (Reuters Health) – Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report in the January 20th online issue of…
NEW YORK (Reuters Health) – How intermittent pneumatic compression compares to graduated compression stockings for preventing deep vein thrombosis (DVT) is still unclear, according to a systematic review…
NEW YORK (Reuters Health) – For acute gout flare, a 1-hour low-dose oral colchicine regimen offers comparable efficacy and better tolerability than the more common 6-hour high-dose regimen,…
NEW YORK (Reuters Health) – In patients with peptic ulcers, eradication of Helicobacter pylori seemed to double the risk of new-onset reflux – but only in cohort study…
NEW YORK (Reuters Health) – Although inhaled corticosteroids (ICS) can help prevent exacerbations of chronic obstructive pulmonary disease (COPD), an analysis of randomized trials suggests that the benefits…
NEW YORK (Reuters Health) – For patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous…
NEW YORK (Reuters Health) – The presence of deep venous thrombosis (DVT) in patients with pulmonary embolism is associated with an increased risk of death, according to a…